Applied behavior analysis, social validation, and the psychopharmacology of mental retardation

Mental Retardation and Developmental Disabilities Research Reviews

Volumn 5, Issue 4, 1999, Pages 342-347

  Poling, Alan ^a   Ehrhardt, Kristal ^a  

^a WESTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

Behavior analysis; Psychotropic medications; Social validation

Indexed keywords

PSYCHOTROPIC AGENT;

BEHAVIOR; HUMAN; INTERVIEW; MENTAL DEFICIENCY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; QUESTIONNAIRE; REVIEW; SOCIAL ASPECT; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 0033387221     PISSN: 10804013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2779(1999)5:4<342::AID-MRDD12>3.0.CO;2-7     Document Type: Review

References (44)

1. Aman MG, Singh NN. 1988. Psychopharmacology of the developmental disabilities. New York: Springer-Verlag.
2. Aman MG, Singh NN, White A. 1987. Caregivers perceptions of psychotropic medication in residential settings. Res Dev Disabil 8:449-465.
3. Baldessarini RJ. 1996. Drugs and the treatment of psychiatric disorders: psychosis and anxiety. In: Hardmann JG, Limbird LE, Molinoff PB, et al., editors. The pharmacological basis of therapeutics. New York: McGraw-Hill. p 399-430.
4. Barlow DH, Hersen M. 1984. Single case experimental designs: strategies for studying behavior change. Elmsford, NY: Pergamon Press.
5. Campbell DT, Stanley JC. 1963. Experimental and quasi-experimental designs for research. Chicago: Rand McNally.
6. Chamber HF, Sande MA. 1996. Antimicrobial agents: general considerations. In: Hardman JG, Limbird LE, Molinoff PB, et al., editors. The pharmacological basis of therapeutics. New York: McGraw-Hill. p 1029-1056.
7. Christian L, Snycerski S, Singh NN, et al. 1999. Direct service staffs perceptions of psychotropic medication in noninstitutional settings for individuals with developmental disabilities. J Intellect Disabil Res 43:88-93.
8. Cooper JO, Heron TE, Heward WL. 1987. Applied behavior analysis. New York: Macmillan.
9. Dermer ML, Hoch TA. 1999. Improving descriptions of single-subject experiments in research texts written for undergraduates. Psychol Rec 49:49-66.
10. Fawcett SB. 1991. Social validity: a note on methodology. J Appl Behav Anal 24:235-239.
11. Fay CH, Latham GP. 1982. Effects of training and rating scales on rating errors. Personnel Psychol 35:105-116.
12. Forehand RL, editor. 1983. Mini-series on consumer satisfaction and behavior therapy. Behav Ther 14:189-246.
13. Fuqua RW, Schwade J. 1986. Social validation of applied behavioral research: a selective review and critique. In: Poling A, Fuqua RW, editors. Research methods in applied behavior analysis. New York: Plenum Press. p 265-292.
14. Gadow KD, Poling A. 1986. Methodological issues in human psychopharmacology: advances in learning and behavioral disabilities. Greenwich, CT: JAI Press.
15. Gadow KD, Poling A. 1988. Pharmacotherapy and mental retardation. Boston: College-Hill.
16. Hawkins RP. 1991. Is social validity what we are interested in? Argument for a functional approach. J Appl Behav Anal 14:205-213.
17. Kazdin AE. 1977. Assessing the clinical or applied importance of behavior change through social validation. Behav Modif 1:427-452.
18. Kazdin AE. 1980. Acceptability of alternative treatments for deviant child behavior. J Appl Behav Anal 13:259-273.
19. Kennedy CH, Meyer KA. 1998. The use of psychotropic medication for people with severe disabilities and challenging behavior: current status and future directions. J Assoc Persons Severe Handicaps 23:83-97.
20. Kollins S, Ehrhardt K, Poling A. In press. Clinical drug assessment. In: Poling A, Byrne T, editors. Introduction to behavioral pharmacology. Reno, NV: Context Press.
21. Lennox D, Miltenberger R. 1990. On the conceptualization of treatment acceptability. Educ Training Ment Retard 25:211-224.
22. Lewis MH, Aman MG, Gadow KD, et al. 1996. Psychopharmacology. In: Facobson JW, JA. Mulick JA, editors. Manual of diagnosis and professional practice in mental retardation. Washington, DC: American Psychological Association. p 323-340.
23. Marshburn EC, Aman MG. 1992. Factor validity and norms for the Aberrant Behavior Checklist in a community sample of children with mental retardation. J Autism Dev Disabil 22:357-373.
24. Martens BK, Witt JC, Elliott SN, Darveaux D. 1985. Teacher judgments concerning the acceptability of school-based interventions. Profess Psychol Res Pract 16:1-1-198.
25. McMahon RJ, Forehand RL. 1983. Consumer satisfaction in behavioral treatment of children: types, issues, and recommendations. Behav Ther 14:209-225.
26. Miltenberger RG. 1990. Assessment of treatment acceptability: a review of the literature. Top Early Child Spec Educ 10:24-38.
27. Poling A, Cleary J. 1986a. The role of applied behavior analysis in evaluating medication effects. In: Poling A, Fuqua RW, editors. Research methods in applied behavior analysis: issues and advances. New York: Plenum Press. p 299-312.
28. Poling A, Cleary J. 1986b. Within-subject designs. In: Gadow KD, Poling A, editors. Methodological issues in human psychopharmacology: advances in learning and behavioral disabilities. Suppl. 1. Greenwich, CT: JAI Press. p 115-136.
29. Poling A, LeSage ML. 1995. Evaluating psychotropic drugs in people with mental retardation: where are the social validity data? Am J Ment Retard 100:193-200.
30. Poling A, Methot LL, LeSage MG. 1995. Fundamentals of behavior analytic research. New York: Plenum Press.
31. Reiss S. 1998. Preface. In: Reiss S, Aman MG, editors. Psychotropic medications and developmental disabilities: the international consensus handbook. Columbus, OH: The Ohio State University Nisonger Center. p 1-2.
32. Rinck C. 1998. Epidemiology and psychoactive medication. In: Reiss S, Aman MG, editors. Psychotropic medications and developmental disabilities: the international consensus handbook. Columbus, OH: The Ohio State University Nisonger Center. p 31-44.
33. Schroeder, SR. 1985. Issues and future directions of psychopharmacology in mental retardation. Psychopharmacol Bull 21 323-326.
34. Schroeder SR, Bouras N, Ellis CR, et al. 1998. Past research on psychopharmacology of people with mental retardation and developmental disabilities. In: Reiss S, Aman MG, editors. Psychotropic medications and developmental disabilities: the international consensus handbook. Columbus, OH: The Ohio State University Nisonger Center. p19-29.
35. Schwartz IS, Baer DM. 1991. Social validity assessments: is current practice state of the art? J Appl Behav Anal 24:189-204.
36. Singh NN, Aman MG. 1990. Ecobehavioral analysis of pharmacotherapy. In: Schroeder SR, editor. Ecobehavioral analysis and developmental disabilities: the twenty-first century. New York: Springer-Verlag. p 182-200.
37. Singh NN, Beale IL. 1986. Behavioral assessment of pharmacotherapy. Behav Change 3: 34-40.
38. Singh NN, Watson JE, Winton ASW. 1987. Parents' acceptability ratings of alternative treatments for use with mentally retarded children. Behav Modif 11:17-26.
39. Singh NN, Ellis C, Donatelli L, et al. 1996. Professionals' perceptions of psychotropic medication in residential facilities for individuals with mental retardation. J Intellect Disabil Res 40:1-7.
40. Spreat S, Lipinski D, Dickerson R, et al. 1989. A paramorphic representation of the acceptability of behavioral programming. Behav Resident Treat 4:1-13.
41. Van Houten R. 1979. Social validation: the evolution of standards of competency for target behaviors. J Appl Behav Anal 12:581-591.
42. Witt JC, Martens BK. 1983. Assessing the acceptability of behavioral interventions used in classrooms. Psychol Schools 20:510-517.
43. Wolf MM. 1978. Social validity: the case for subjective measurement or how applied behavior analysis is finding its heart. J Appl Behav Anal 11:203-215.
44. Wysocki T, Fuqua RW. 1982. Methodological issues in the evaluation of drug effects. In: Breuning SE, Poling A, editors. Drugs and mental retardation. Springfield, IL: Charles C Thomas. p 138-167.